C21 Investments Inc. (CWLXF): Shareholders' Equity

Annual figures by period end, from SEC filings.

$25.43M
As of 2026-03-31
$34.32M2021-01-31: $23.26M2022-01-31: $33.73M2023-01-31: $34.32M2024-01-31: $31.05M2024-03-31: $30.97M2025-03-31: $28.68M2026-03-31: $25.43M$25.43M
2021-01-31 Shareholders' Equity (USD) 2026-03-31
Period endedShareholders' EquityChange YoYSource filing
2026-03-31$25.43M-11.3%2026-06-12, Balance as of period end
2025-03-31$28.68M-7.4%2026-06-12, Balance as of period end
2024-03-31$30.97Mn/a2025-06-23, Balance as of period end
2024-01-31$31.05M-9.5%2025-06-23, Balance as of period end
2023-01-31$34.32M+1.7%2024-08-08, Balance as of period end
2022-01-31$33.73M+45.0%2023-07-28, Balance as of period end
2021-01-31$23.26Mn/a2023-07-28, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$25.43M-11.3%
Leef Brands Inc. (LEEEF)2025-12-31-$8.27Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$23.13Mn/m
Cyanotech Corp (CYAN)2025-03-31$8.88M-24.8%
Charlie's Holdings, Inc. (CHUC)2025-12-31$3.42Mn/m
Bon Natural Life Ltd (BON)2025-09-30$58.00M+30.8%
Fitlife Brands, Inc. (FTLF)2025-12-31$43.64M+20.8%
Mannatech Inc (MTEX)2025-12-31-$5.22Mn/m
Niagen Bioscience, Inc. (NAGE)2025-12-31$76.53M+66.0%

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗